Home > Drugs A – Z > Peginesatide (Injection)
  • We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Peginesatide (Injection)

Treats anemia in patients who have chronic kidney disease (CKD) and are on dialysis. This medicine was withdrawn from the US market in February 2013 because it may cause serious allergic reactions.

Peginesatide injection is used to treat anemia in patients with chronic kidney disease (CKD) who are on dialysis. This medicine was available only with your doctor's prescription. Peginesatide was voluntarily withdrawn from the U.S. market on February 24, 2013 due to safety concerns for serious allergic reactions… Read more
Drug classes About this
Hematopoietic

PubMed Health Blog...

read all...